Provider | |
---|---|
peyman mottaghi , MDAssociate Professor
School :School of MedicineDepartment :Department of Internal MedicineResearch Center :Psychosomatic research centerwork address :Alzahra hospital-Esfahan-IRANEducation :Internal medicine: Isfahan University of Medical Sciences-IRAN (1993-1996) Rheumatology training: Shiraz University of Medical Sciences-IRAN (2000-2001)Relevant Work Experience :Sharehcord University of Medical Sciences-Internist (academic stuff 1396-1399) Isfahan University of Medical Sciences -Isfahan-IRAN (academic stuff 2002– now) Deputy Vice Chancellor for Research, School of Medicine -IUMS (2015-2017) Secretary of continuing medical education -IUMS (2018-2019) Head of Rheumatology division, Department of Internal MedicineProfessional Memberships & Qualification :Extra Curricular Activities/ Interest(personal url) :Grants & Awards :Patents :Presentations & Poster Sessions :Research Experience :Antioxidant and Bone; Protect Your Future: A Brief Review. Mottaghi P, Nasri P. Iran J Public Health. 2021 Sep;50(9):1783-1788. - A Phase IV Study of the Safety and Efficacy of CinnoPar® in Iranian Patients with Osteoporosis. Jamshidi A, Gharibdoost F, Sedighi S, Hajiabbasi A, Salari AH, Khabbazi A, Mottaghi P. J Osteoporos. 2021 May 31; 2021:7584308. - The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids. Karimifar M, Sepehrifar MS, Moussavi H, Sepehrifar MB, Mottaghi P, Siavash M, Karimifar M.J Res Med Sci. 2018 Dec 28;23:105-109. - Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-Marketing Surveillance Study. Gharibdoost F, Salari AH, Salesi M, Ebrahimi Chaharom F, Mottaghi P, Hosseini M, Sahebari M, Nazarinia M, Mirfeizi Z, Shakibi M, Moussavi H, Karimifar M, Mowla K, Karimzadeh H, Anjidani N, Jamshidi A. Adv Ther. 2021 Feb;38(2):1290-1300. - Intravenous pamidronate for refractory rheumatoid arthritis. Salesi M, Mottaghi P, Karimifar M, Farajzadegan Z.J Res Med Sci. 2012 May;17(5):422-7. - Intravenous bisphosphonates for postmenopausal osteoporosis. Mottaghi P.J Res Med Sci. 2010 May;15(3):175-84. - Prevalence of Chondrocalcinosis in Patients above 50 Years and the Relationship with Osteoarthritis. Karimzadeh H, Sirous M, Sadati SN, Bashshash M, Mottaghi P, Ommani B, Karimifar M. Adv Biomed Res. 2017 Jul 31;6:98.101 - Serum cryoglobulins and disease activity in systematic lupus erythematosus. Karimifar M, Pourajam S, Tahmasebi A, Mottaghi P.J Res Med Sci. 2013 Mar;18(3):234-8. - Intravenous pamidronate for refractory lymphedema. Beigi AA, Sadeghi AM, Masoudpour H, Shirazinejad S, Mottaghi P. Iran Red Crescent Med J. 2011 Apr;13(4):263-6 Venous insufficiency after prolonged standing: Is joint hypermobility an important risk factor? Azma K, Mottaghi P, Hosseini A, Salek S, Bina R. Adv Biomed Res. 2015 May 11;4:98-102 - Predictors and effective factors on quality of life among Iranian patients with rheumatoid arthritis. Karimi S, Yarmohammadian MH, Shokri A, Mottaghi P, Qolipour K, Kordi A, Bahman Ziari N.Mater Sociomed. 2013;25(3):158-62. - Severe cognitive dysfunction in a patient with polyendocrinopathy. Dastjerdi MS, Aminorroaya A, Amini M, Ashrafi F, Kazemi F, Saadatnia M, Mottaghi P, Emami A.Exp Clin Endocrinol Diabetes. 2007 May;115(5):334-8. - Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala). Mottaghi P. J Res Med Sci. 2013, Apr;18(4):366-7. - Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise. Salesi M, Mottaghi P.J Res Med Sci. 2011 May;16(5):703-6. - Benign joint hypermobility syndrome in soldiers; what is the effect of military training courses on associated joint instabilities? Azma K, Mottaghi P, Hosseini A, Abadi HH, Nouraei MH. J Res Med Sci. 2014 Jul;19(7):639-43.Research Interests :Rheumatologic disease myositis, SclerodermaTeaching Experience :2001-2022: ICM course, Isfahan University of Medical SciencesTeaching Interests :Rheumatologic diseases |